Clin Cancer Res (2025) 31 (1): 217–224. The Clinical Cancer Research editors wish to acknowledge with sincere appreciation the assistance of the following reviewers who have generously contributed ...
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 3Clinical and ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Search for other works by this author on: ...
1Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum – MKFZ, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany.
Glutathione S-Transferase P (GSTP) known as a Phase II detoxification enzyme has more recently been identified as a modulator of MAP kinase-related cell-signaling pathways. It is known to be ...
Innovent Biologics will license IBI3009, its investigational DLL3-targeted antibody–drug conjugate (ADC) for small cell lung cancer (SCLC), to Roche for $80 million upfront and payments totaling up to ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback